Alfresa Holdings Corporation (TYO:2784)

Japan · Delayed Price · Currency is JPY

2,299.00

+4.00 (0.17%)

Nov 13, 2026, 3:30 PM JST

Market Cap	403.28B -2.4%
Revenue (ttm)	3.16T +4.0%
Net Income	38.47B +54.8%
EPS	214.40 +58.0%
Shares Out	175.41M
PE Ratio	10.72
Forward PE	16.23
Dividend	71.00 (3.09%)
Ex-Dividend Date	Mar 30, 2027

Volume	412,000
Open	2,255.50
Previous Close	2,295.00
Day's Range	2,248.00 - 2,310.00
52-Week Range	2,106.50 - 2,685.50
Beta	-0.19
Analysts	Hold
Price Target	2,226.67 (-3.15%)
Earnings Date	Nov 9, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. The company operates through Wholesale of Prescription Drugs and Related Products, Wholesale of Self-Medication Products, Manufacturing of Pharmaceuticals and Related Products, and Pharmacy and Related Businesses segments. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethic... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2003

Employees 12,525

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 2784

Full Company Profile

Financial Performance

In fiscal year 2026, Alfresa Holdings's revenue was 3.10 trillion, an increase of 4.83% compared to the previous year's 2.96 trillion. Earnings were 41.75 billion, an increase of 52.42%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 2784 stock is "Hold." The 12-month stock price target is ¥2,227, which is a decrease of -3.15% from the latest price.

Price Target

¥2,227

(-3.15% downside)

Analyst Consensus: Hold

Stock Forecasts